Bhattacharya's nomination, alongside Robert F. Kennedy Jr. and Mehmet Oz, indicates potential shifts in vaccine policy under ...

Tyler Sandahl, PharmD, of Mayo Clinic, and Michael Byrne, DO, of Tennessee Oncology, discuss practical advice for bringing ...

A review of recent clinical trial results for emerging HER2-directed therapies, including SOHO-01, inetetamab/pyrotinib, and ...

Real-world outcomes for HER2-positive NSCLC differ from clinical trials due to diverse patient populations and treatment ...

An exploration of emerging strategies to overcome resistance to HER2-directed therapies based on ongoing research advancements.

On this episode of Managed Care Cast, we speak with the author of a study published in the November 2024 issue of The ...

If made official, the proposed rule would give Part D and Medicaid beneficiaries expanded coverage to antiobesity drugs ...

The panelist discusses how antibiotics are paradoxically both the primary treatment for Clostridioides difficile infections ...

The oral solution offers precise dosing, benefiting patients with swallowing difficulties or requiring tailored dosing.

Vermont achieved the highest ranking in maternal and infant health with a preterm birth rate of 7.7%, the lowest in the ...

For some patients with myasthenia gravis (MG), activity and sleep were associated with reported fatigue and symptom levels.

Patients with treatment-resistant central centrifugal cicatricial alopecia saw improvement in symptoms and gene expression, ...